av/quantum-genomics-sas-regr--big.svg

EURONEXT:ALQGC

Quantum Genomics Société Anonyme

  • Stock

EUR

Last Close

0.10

26/07 14:51

Market Cap

6.76M

Beta: 0.20

Volume Today

23.13K

Avg: 469.87K

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-1.54M
-
-2.21M
43.21%
-3.76M
70.57%
-5.24M
39.24%
-9.38M
78.98%
-11.99M
27.81%
-9.89M
17.55%
-16.22M
64.11%
-17.36M
7.00%
-24.94M
43.65%
-3.17M
87.28%
depreciation and amortization
9K
-
15.04K
67.14%
24.21K
60.94%
26.95K
11.31%
25.87K
4.01%
19.02K
26.48%
153K
704.50%
137K
10.46%
390K
184.67%
263.77K
32.37%
deferred income tax
517K
-
-635K
222.82%
-818K
28.82%
stock based compensation
859K
-
1.48M
72.29%
1.57M
5.95%
change in working capital
545K
-
25K
95.41%
-7K
128%
-318K
4,442.86%
767K
341.19%
-178K
123.21%
-1.38M
673.03%
1.09M
179.43%
-1.57M
243.37%
59.83K
103.82%
accounts receivables
-9K
-
25K
377.78%
7K
72%
-233K
3,428.57%
-823K
-
763K
192.71%
59.83K
92.16%
inventory
865K
-
-14K
101.62%
-997K
7,021.43%
767K
176.93%
-178K
123.21%
89K
150%
-1.41M
1,688.76%
accounts payables
-655K
-
832K
227.02%
801K
3.73%
1.94M
-
767K
60.50%
other working capital
554K
-
655K
18.23%
-832K
227.02%
111K
113.34%
-1.47M
-
1.39M
194.74%
-3.10M
323.13%
other non cash items
-624.17K
-
605.06K
196.94%
1.41K
99.77%
611.31K
43,224.31%
1.25M
104.16%
-695K
155.69%
2.16M
410.22%
769K
64.33%
4.40M
472.06%
3.17M
27.92%
net cash provided by operating activities
-987K
-
-2.79M
182.78%
-3.14M
12.58%
-5.53M
76.03%
-7.98M
44.22%
-10.90M
36.66%
-10.43M
4.34%
-11.99M
15.01%
-17.02M
41.89%
-20.21M
18.78%
investments in property plant and equipment
-112K
-
-25K
77.68%
-22K
12%
-67K
204.55%
-8K
88.06%
-16K
100%
-116K
625%
-411K
254.31%
-45K
89.05%
acquisitions net
purchases of investments
-46K
-
-296K
543.48%
-141K
52.36%
-215K
-
-32.54K
-
sales maturities of investments
114K
-
105K
-
other investing activites
-279K
-
-50K
82.08%
40K
-
-105K
-
-120K
-
net cash used for investing activites
-112K
-
-350K
212.50%
-368K
5.14%
-208K
43.48%
146K
170.19%
-231K
258.22%
-116K
49.78%
-411K
254.31%
-45K
89.05%
-152.54K
238.97%
debt repayment
-419K
-
-2.27M
440.57%
-3.31M
45.96%
-10K
-
-462K
-
-27K
94.16%
-2.75M
10,085.19%
common stock issued
831K
-
3.70M
345.13%
12.15M
228.47%
7.74M
36.26%
7.73M
0.14%
15.07M
94.89%
7.38M
51.02%
28.50M
286.09%
846K
97.03%
17.18M
1,931.01%
common stock repurchased
dividends paid
other financing activites
968K
-
162K
83.26%
540K
-
-231K
-
-8K
96.54%
-87K
987.50%
-136K
56.32%
31.62K
123.25%
net cash used provided by financing activities
1.38M
-
6.13M
343.91%
8.84M
44.37%
8.28M
6.33%
7.72M
6.77%
14.84M
92.15%
6.91M
53.42%
28.39M
310.69%
3.46M
87.81%
17.21M
397.51%
effect of forex changes on cash
-1K
-
-1K
0%
6K
-
55
-
net change in cash
280K
-
2.98M
965.71%
5.33M
78.75%
-2.35M
144.14%
-108K
95.41%
3.71M
3,533.33%
-3.63M
197.95%
24.96M
787.09%
-13.60M
154.50%
-3.15M
76.83%
cash at beginning of period
54K
-
334K
518.52%
3.32M
893.41%
4.55M
37.19%
11.20M
145.98%
11.09M
0.96%
14.80M
33.44%
2.20M
85.15%
27.15M
1,135.48%
13.55M
50.09%
10.40M
23.25%
cash at end of period
334K
-
3.32M
893.41%
8.65M
160.76%
2.20M
74.60%
11.09M
404.56%
14.80M
33.44%
11.16M
24.55%
27.15M
143.20%
13.55M
50.09%
10.40M
23.25%
10.40M
0%
operating cash flow
-987K
-
-2.79M
182.78%
-3.14M
12.58%
-5.53M
76.03%
-7.98M
44.22%
-10.90M
36.66%
-10.43M
4.34%
-11.99M
15.01%
-17.02M
41.89%
-20.21M
18.78%
capital expenditure
-112K
-
-25K
77.68%
-22K
12%
-67K
204.55%
-8K
88.06%
-16K
100%
-116K
625%
-411K
254.31%
-45K
89.05%
free cash flow
-1.10M
-
-2.82M
156.23%
-3.16M
12.36%
-5.60M
76.93%
-7.99M
42.64%
-10.92M
36.72%
-10.54M
3.42%
-12.40M
17.64%
-17.06M
37.55%
-20.21M
18.47%

All numbers in EUR (except ratios and percentages)